Related Experiment Video

Updated: Jun 3, 2026

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
07:42

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract

Published on: July 1, 2020

Update on invasive mycoses by filamentous fungi in critically ill patients

Javier Pemán1, Pilar Luque, Mercedes Nieto

  • 1Servicio de Microbiología, Hospital Universitario La Fe, Valencia, Spain. peman_jav@gva.es

Enfermedades Infecciosas Y Microbiologia Clinica
|April 5, 2011
PubMed

Insights

This review updates knowledge on invasive fungal infections in critically ill patients, focusing on filamentous fungi. It highlights key findings in causative agents, epidemiology, and diagnosis for better patient outcomes.

Area of Science:

  • Critical Care Medicine
  • Mycology
  • Infectious Diseases

Background:

  • Invasive fungal infections (IFIs) pose a significant threat to critically ill patients.
  • Filamentous fungi are increasingly recognized as important pathogens in intensive care units (ICUs).
  • Early diagnosis and treatment are crucial for improving survival rates in patients with IFIs.

Purpose of the Study:

  • To provide an updated literature review on IFIs caused by filamentous fungi in critically ill patients.
  • To discuss recent advances in the epidemiology, diagnosis, and treatment of these infections.
  • To assess strategies for early identification and management of at-risk patients in the ICU.

Main Methods:

  • A multidisciplinary panel of Spanish physicians reviewed and discussed recent literature.
  • Key articles on filamentous fungal infections in critically ill patients were selected.
  • The analysis covered causative microorganisms, epidemiology, diagnosis, and treatment strategies.

Main Results:

  • The review synthesizes current knowledge on filamentous fungal infections in the ICU.
  • It emphasizes the importance of understanding specific causative agents and their epidemiological trends.
  • Diagnostic challenges and therapeutic options are critically evaluated.

Conclusions:

  • Prompt identification and management of filamentous fungal infections are vital in critically ill patients.
  • Continuous updates in diagnostic and therapeutic strategies are necessary for optimal patient care.
  • Multidisciplinary collaboration is essential for addressing the complexities of IFIs in the ICU setting.

More Related Videos

Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis08:48

Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis

Published on: March 19, 2019

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Fungal Group Zygomycota01:29

Fungal Group Zygomycota

Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...